Dr. Marc McCaslin Holden, MD

Dr. Holden practices at Genesis Healthcare Partners in San Diego, California.

Dr. Holden's NPI, 1861747396, was assigned on July 20, 2012. Dr. Holden graduated from Vagelos College of Physicians and Surgeons in 2012. Dr. Holden's California license number on file is A129770.

Dr. Holden's primary practice is Genesis Healthcare Partners, at 3366 5th Ave, San Diego, CA 92103 in San Diego County. The practice phone is (760) 436-4558.

Dr. Holden's primary practice is Genesis Healthcare Partners in San Diego, California. Dr. Holden is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Holden to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holden practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Holden's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Holden is board certified in urology by the American Board of Urology. Dr. Holden has a license on file in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Holden treats.

CMS data shows 3,047 Medicare services from Dr. Holden across 24 procedure codes in 2024, for 493 Medicare patients. Medicare paid $157,747 for them.

CMS counts 493 Medicare patients who saw Dr. Holden in 2024. The largest group is 65 to 74, with 262 patients. 74% of them have high cholesterol, and 73% have high blood pressure. 40% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Holden's median patient age at 69, with 23% women.

In 2024, Dr. Holden wrote 1,258 Medicare Part D claims for 390 patients. 80% of them were for generic drugs. CMS names the drug for 1,145 of them, across 11 drugs with 11 or more claims each, at $233,762 in total drug cost. In 2023, CMS named 996 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Holden for performance year 2024, reported as part of a group. Dr. Holden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holden as offering telehealth. CMS counts 20 procedures of removal of skin lesions by Dr. Holden, more than 65% of the clinicians it reports for that procedure.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Holden, published from 2014 to 2017. 2014 was the busiest year, with 2. The most frequent topics are Operative Time. Dr. Holden's most frequent co-authors are Sean W. Berquist, Ithaar Derweesh, MD and Michael Andre Liss, MD.

CMS Open Payments shows 393 general payments to Dr. Holden from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Teleflex LLC paid the most, $1,138.

Dr. Holden graduated from Vagelos College of Physicians and Surgeons in 2012.

Dr. Holden is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.